The key cause of high drug prices is a social disease called “maximizing shareholder value”

  • Axios reported that top pharmaceutical companies have announced significant so called ‘buybacks,’ which benefit shareholders by driving up the value of their stock.
  • Contributions to Republican Party have yielded a great ROI for pharma.
  • This suggests that pharmaceutical companies have used these tax breaks to enrich investors, a decision that comes at the expense of lowering the price of prescription drugs, investing in research and development that could lead to new cures, or passing along savings to consumers.”

Continue reading